- Home
- BLX vs MDXG Comparison
BLX vs MDXG Comparison
Compare BLX & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLX
- MDXG
- Stock Information
- Founded
- BLX 1977
- MDXG 2006
- Country
- BLX Panama
- MDXG United States
- Employees
- BLX N/A
- MDXG N/A
- Industry
- BLX Commercial Banks
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- BLX Finance
- MDXG Health Care
- Exchange
- BLX Nasdaq
- MDXG Nasdaq
- Market Cap
- BLX 1.4B
- MDXG 1.2B
- IPO Year
- BLX N/A
- MDXG N/A
- Fundamental
- Price
- BLX $38.30
- MDXG $6.76
- Analyst Decision
- BLX
- MDXG Strong Buy
- Analyst Count
- BLX 0
- MDXG 3
- Target Price
- BLX N/A
- MDXG $12.00
- AVG Volume (30 Days)
- BLX 162.2K
- MDXG 541.7K
- Earning Date
- BLX 05-05-2025
- MDXG 04-30-2025
- Dividend Yield
- BLX 6.59%
- MDXG N/A
- EPS Growth
- BLX 23.03
- MDXG N/A
- EPS
- BLX 5.60
- MDXG 0.28
- Revenue
- BLX $286,325,000.00
- MDXG $348,879,000.00
- Revenue This Year
- BLX $15.35
- MDXG $10.04
- Revenue Next Year
- BLX $6.42
- MDXG $11.53
- P/E Ratio
- BLX $6.76
- MDXG $24.33
- Revenue Growth
- BLX 19.98
- MDXG 8.52
- 52 Week Low
- BLX $27.37
- MDXG $5.47
- 52 Week High
- BLX $42.88
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- BLX 56.22
- MDXG 37.46
- Support Level
- BLX $36.52
- MDXG $6.50
- Resistance Level
- BLX $38.34
- MDXG $7.34
- Average True Range (ATR)
- BLX 1.49
- MDXG 0.34
- MACD
- BLX 0.37
- MDXG -0.01
- Stochastic Oscillator
- BLX 88.56
- MDXG 29.17
About BLX Banco Latinoamericano de Comercio Exterior S.A.
Banco Latinoamericano de Comercio Exterior SA provides financial solutions to financial institutions, companies, and investors doing business in Latin America, supporting trade and regional integration across the region. The Bank provides foreign trade solutions to a select client base of premier Latin-American financial institutions and corporations and has developed a network of correspondent banking institutions with access to the international capital markets. It has two business segments the Commercial Business Segment and the Treasury Business Segment.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.